I 
117TH CONGRESS 
1ST SESSION H. R. 2364 
To amend title III of the Public Health Service Act to direct the Secretary, 
acting through the Director of the Centers for Disease Control and 
Prevention, to provide for a public education campaign to raise public 
awareness of synthetic opioids. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 5, 2021 
Mr. KIM of New Jersey (for himself and Mr. PAPPAS) introduced the following 
bill; which was referred to the Committee on Energy and Commerce 
A BILL 
To amend title III of the Public Health Service Act to 
direct the Secretary, acting through the Director of the 
Centers for Disease Control and Prevention, to provide 
for a public education campaign to raise public awareness 
of synthetic opioids. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Synthetic Opioid Dan-
ger Awareness Act’’. 
VerDate Sep 11 2014 
21:22 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H2364.IH
H2364
pamtmann on DSKBC07HB2PROD with BILLS
SEC. 2. SYNTHETIC OPIOIDS PUBLIC AWARENESS CAM-
PAIGN. 
Part B of title III of the Public Health Service Act 
is amended by inserting after section 317U (42 U.S.C. 
247b–23) the following new section: 
‘‘SEC. 317V. SYNTHETIC OPIOIDS PUBLIC AWARENESS CAM-
PAIGN. 
‘‘(a) IN GENERAL.—Not later than one year after the 
date of the enactment of this section, the Secretary, acting 
through the Director of the Centers for Disease Control 
and Prevention, shall provide for the planning and imple-
mentation of a public education campaign to raise public 
awareness of synthetic opioids (including fentanyl and its 
analogues). Such campaign shall include the dissemination 
of information that— 
‘‘(1) promotes awareness about the potency and 
dangers of fentanyl and its analogues and other syn-
thetic opioids; 
‘‘(2) explains services provided by the Sub-
stance Abuse and Mental Health Services Adminis-
tration and the Centers for Disease Control and 
Prevention (and any entity providing such services 
under a contract entered into with such agencies) 
with respect to the abuse of opioids, particularly as 
such services relate to the provision of alternative, 
non-opioid pain management treatments; and 
VerDate Sep 11 2014 
21:22 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H2364.IH
H2364
pamtmann on DSKBC07HB2PROD with BILLS
‘‘(3) relates generally to opioid use and pain 
management. 
‘‘(b) USE OF MEDIA.—The campaign under sub-
section (a) may be implemented through the use of tele-
vision, radio, internet, in-person public communications, 
and other commercial marketing venues and may be tar-
geted to specific age groups. 
‘‘(c) CONSULTATION.—In coordinating the campaign 
under subsection (a), the Secretary, acting through the 
Director shall consult with the Assistant Secretary for 
Mental Health and Substance Use to provide ongoing ad-
vice on the effectiveness of information disseminated 
through the campaign. 
‘‘(d) REQUIREMENT OF CAMPAIGN.—The campaign 
implemented under subsection (a) shall not be duplicative 
of any other Federal efforts relating to eliminating the 
abuse of opioids. 
‘‘(e) EVALUATION.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director, shall ensure that the campaign 
implemented under subsection (a) is subject to an 
independent evaluation, beginning 2 years after the 
date of the enactment of this section, and every 2 
years thereafter. 
VerDate Sep 11 2014 
21:22 Jun 09, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H2364.IH
H2364
pamtmann on DSKBC07HB2PROD with BILLS